MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

Search

Phibro Animal Health Corp

Closed

Sector Healthcare

22.45 -2.31

Overview

Share price change

24h

Current

Min

22.37

Max

22.53

Key metrics

By Trading Economics

Income

-3.8M

3.2M

Sales

49M

309M

P/E

Sector Avg

50.354

73.394

EPS

0.54

Dividend yield

1.99

Profit margin

1.03

Employees

1,940

EBITDA

-4.9M

26M

Recommendations

By TipRanks

Recommendations

Sell

12 Months Forecast

+5.56 upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.99%

3.09%

Next Earnings

7 May 2025

Next Dividend date

26 Mar 2025

Next Ex Dividend date

5 Mar 2025

Market Stats

By TradingEconomics

Market Cap

448M

979M

Previous open

24.76

Previous close

22.45

News Sentiment

By Acuity

50%

50%

157 / 393 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

Phibro Animal Health Corp Chart

Past performance is not a reliable indicator of future results.

Related News

29 Apr 2024, 10:57 UTC

Acquisitions, Mergers, Takeovers

Zoetis to Sell Medicated-Feed-Additive Portfolio to Phibro for $350 Million

Peer Comparison

Price change

Phibro Animal Health Corp Forecast

Price Target

By TipRanks

5.56% upside

12 Months Forecast

Average 23.75 USD  5.56%

High 27 USD

Low 21 USD

Based on 4 Wall Street analysts offering 12 month price targets forPhibro Animal Health Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Sell

4 ratings

0

Buy

2

Hold

2

Sell

Technical Score

By Trading Central

N/A / 24.4Support & Resistance

Short Term

Strong Bearish Evidence

Intermediate Term

Weak Bullish Evidence

Long Term

Bullish Evidence

Sentiment

By Acuity

157 / 393 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Phibro Animal Health Corp

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.